APOE and Alzheimer disease: Supporting this interpretation, we found a significantly higher frequency of APOE ε4 carriers—the strongest genetic risk factor for AD [62]—in CSF A + T + individuals compared to CSF A + T − individuals (79% vs. 22%), consistent with a more canonical AD-driven process (Fig. 3).